FeesSafety
Pluang+

A Hyperliquid address shorting UNITREE perpetual lost over $430K amid rising prices and negative funding.

Market News
09 Nov 2026, 09:28 WIB
Tokenpost
View Source
Bearish
A Hyperliquid address shorting UNITREE perpetual lost over $430K amid rising prices and negative funding.

A Hyperliquid address shorting the UNITREE perpetual contract has incurred over $430,400 in combined realized and unrealized losses since October 20, as the contract price rose to $104.26 on November 9. Despite seven consecutive negative hourly funding settlements that cost shorts money, the short position held about $1.09 million at an average entry price of $94.06 and faced an estimated liquidation price of $124.36. The rising contract price alongside negative funding rates highlights the risks of shorting in volatile markets, with the position's losses including about $210,800 from partial buybacks and $112,100 in net funding payments. This case underscores the financial strain shorts can face when prices increase despite negative funding rates, signaling caution for traders using leverage in perpetual contracts.

UNITREE Short's funding and losses provide context for cryptocurrency market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 09, 2026 13:51 WIB: out of 50 priced major cryptocurrencies, 6 rose and 43 fell today. Notable movers include ALGO at Rp1.647 with a 1-day change of -4.08% and a typical hold time on Pluang of 131 days, KSM at Rp55.878 down 3.99%, and FIL at Rp13.633 down 3.95% with 84% sell order activity. The most notable figure is ALGO's 73% sell order activity.

More News

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis Holding AG announced an in-person and virtual R&D Day on December 8, 2026, to highlight key clinical developments in its late-stage pipeline, including Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmology and neurology. The...

Market News
Bullish
42 minutes ago
DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA announced that its offer to acquire Capricorn Energy plc has lapsed as of November 9, 2026. This means the acquisition attempt will not proceed, impacting DNO's expansion plans in the oil and gas sector. Investors should monitor DNO's next st...

Market News
Neutral
42 minutes ago
Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis Holding AG will hold a Research & Development Day on December 8, 2026, to present key clinical progress on its late-stage drug candidates Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmic conditions including optic neuritis...

Company Fundamentals
Bullish
42 minutes ago
Fraudulent robocall losses in North America to drop 33% by 2031 due to advanced fraud prevention.

Fraudulent robocall losses in North America to drop 33% by 2031 due to advanced fraud prevention.

Juniper Research forecasts that losses from fraudulent robocalls in North America will decrease by 33%, from $18.4 billion in 2026 to $12.3 billion in 2031. This decline is attributed to telecom operators adopting advanced fraud prevention technologi...

Market News
Bullish
42 minutes ago
Dimensional's DFIV ETF outperforms peers with lower fees and strong value discount since 2025

Dimensional's DFIV ETF outperforms peers with lower fees and strong value discount since 2025

Dimensional's International Value ETF (DFIV) offers active management with a lower fee of 0.27% compared to similar ETFs like iShares' EFV and IVLU. Through September 30, DFIV has outperformed its benchmark by about 1% annually after fees over five a...

Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App